Similar articles for PMID: 31491447

Year	Number of Results
2001	1
2003	1
2005	1
2006	3
2007	2
2008	2
2009	5
2010	5
2011	9
2012	10
2013	11
2014	15
2015	11
2016	8
2017	13
2018	11
2019	16
2020	13
2021	14
2022	20
2023	7
2024	0

1

SRSF1 and RBM4 differentially modulate the oncogenic effect of HIF-1α in lung cancer cells through alternative splicing mechanism.

Chang HL, Lin JC. Chang HL, et al. Biochim Biophys Acta Mol Cell Res. 2019 Dec;1866(12):118550. doi: 10.1016/j.bbamcr.2019.118550. Epub 2019 Sep 3. Biochim Biophys Acta Mol Cell Res. 2019. PMID: 31491447 Free article.

2

RBM4-SRSF3-MAP4K4 splicing cascade modulates the metastatic signature of colorectal cancer cell.

Lin JC, Lee YC, Tan TH, Liang YC, Chuang HC, Fann YC, Johnson KR, Lin YJ. Lin JC, et al. Biochim Biophys Acta Mol Cell Res. 2018 Feb;1865(2):259-272. doi: 10.1016/j.bbamcr.2017.11.005. Epub 2017 Nov 11. Biochim Biophys Acta Mol Cell Res. 2018. PMID: 29138007 Free article.

3

Hypoxia inducible factor-1α/vascular endothelial growth factor signaling activation correlates with response to radiotherapy and its inhibition reduces hypoxia-induced angiogenesis in lung cancer.

Zhu H, Zhang S. Zhu H, et al. J Cell Biochem. 2018 Sep;119(9):7707-7718. doi: 10.1002/jcb.27120. Epub 2018 Jun 15. J Cell Biochem. 2018. PMID: 29904944

4

Identification of alternative splicing events regulated by the oncogenic factor SRSF1 in lung cancer.

de Miguel FJ, Sharma RD, Pajares MJ, Montuenga LM, Rubio A, Pio R. de Miguel FJ, et al. Cancer Res. 2014 Feb 15;74(4):1105-15. doi: 10.1158/0008-5472.CAN-13-1481. Epub 2013 Dec 26. Cancer Res. 2014. PMID: 24371231

5

SRSF1 modulates PTPMT1 alternative splicing to regulate lung cancer cell radioresistance.

Sheng J, Zhao Q, Zhao J, Zhang W, Sun Y, Qin P, Lv Y, Bai L, Yang Q, Chen L, Qi Y, Zhang G, Zhang L, Gu C, Deng X, Liu H, Meng S, Gu H, Liu Q, Coulson JM, Li X, Sun B, Wang Y. Sheng J, et al. EBioMedicine. 2018 Dec;38:113-126. doi: 10.1016/j.ebiom.2018.11.007. Epub 2018 Nov 11. EBioMedicine. 2018. PMID: 30429088 Free PMC article.

6

Altered VEGF Splicing Isoform Balance in Tumor Endothelium Involves Activation of Splicing Factors Srpk1 and Srsf1 by the Wilms' Tumor Suppressor Wt1.

Wagner KD, El Maï M, Ladomery M, Belali T, Leccia N, Michiels JF, Wagner N. Wagner KD, et al. Cells. 2019 Jan 11;8(1):41. doi: 10.3390/cells8010041. Cells. 2019. PMID: 30641926 Free PMC article.

7

The splicing factor RBM4 controls apoptosis, proliferation, and migration to suppress tumor progression.

Wang Y, Chen D, Qian H, Tsai YS, Shao S, Liu Q, Dominguez D, Wang Z. Wang Y, et al. Cancer Cell. 2014 Sep 8;26(3):374-389. doi: 10.1016/j.ccr.2014.07.010. Cancer Cell. 2014. PMID: 25203323 Free PMC article.

8

Oncogenic splicing factor SRSF1 is a critical transcriptional target of MYC.

Das S, Anczuków O, Akerman M, Krainer AR. Das S, et al. Cell Rep. 2012 Feb 23;1(2):110-7. doi: 10.1016/j.celrep.2011.12.001. Cell Rep. 2012. PMID: 22545246 Free PMC article.

9

The impact of the RBM4-initiated splicing cascade on modulating the carcinogenic signature of colorectal cancer cells.

Lin JC, Lee YC, Liang YC, Fann YC, Johnson KR, Lin YJ. Lin JC, et al. Sci Rep. 2017 Mar 9;7:44204. doi: 10.1038/srep44204. Sci Rep. 2017. PMID: 28276498 Free PMC article.

10

Molecular and functional evaluation of a novel HIF inhibitor, benzopyranyl 1,2,3-triazole compound.

Park K, Lee HE, Lee SH, Lee D, Lee T, Lee YM. Park K, et al. Oncotarget. 2017 Jan 31;8(5):7801-7813. doi: 10.18632/oncotarget.13955. Oncotarget. 2017. PMID: 27999195 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

153 results

Results by year